Longboard Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Longboard Pharmaceuticals generated cash of -$50,868,000, which is less than the previous year. Cash used in financing activities reached the amount of $30,191,000 last year. Net change in cash is therefore $3,556,000.
Cash Flow
| 2020 | -3.44M | 0 | 58.75M |
|---|---|---|---|
| 2021 | -24.70M | -40.71M | 76.45M |
| 2022 | -38.06M | -17.06M | -444K |
| 2023 | -50.86M | 24.23M | 30.19M |
LBPH Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 10.77M | 66.34M | 55.31M | 0 |
Operating activities | ||||
Net income | -54.42M | -43.94M | -27.79M | -14.4M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 5K | 5K | 1K | 0 |
Stock-based compensation expense | 3.25M | 2.65M | 1.96M | 8.50M |
| Deferred income tax benefit | 3.25M | 2.65M | 1.96M | 8.50M |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -308K | 282K | -185K | 1.21M |
Cash generated by operating activities | -50.86M | -38.06M | -24.70M | -3.44M |
Investing activities | ||||
Purchases Of Investments | -71.71M | -57.61M | -40.7M | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -16K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 24.23M | -17.06M | -40.71M | 0 |
Financing activities | ||||
Common Stock Issued | 31.78M | 0 | 76.45M | 55.55M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -1K | -205K |
Repayments of term debt | 0 | 0 | 0 | 0 |
Cash used in financing activities | 30.19M | -444K | 76.45M | 58.75M |
Net Change In Cash | 3.55M | -55.57M | 11.03M | 55.31M |
Cash at end of period | 14.33M | 10.77M | 66.34M | 55.31M |
| Data source | Data source | Data source |